Sort
40,608 grants matching “prostate cancer”
Targeting a Novel Epigenetic Signaling Nexus ACK1-pY88H4-AR/AR-V7 in Drug Resistant Metastatic Prostate Cancer
$338,664Nupam P Mahajan · Washington University · R01 · FY2021 · CA
TRP Ca2+ Channels in the Skin
$338,627Haoxing Xu · University Of Michigan At Ann Arbor · R01 · FY2015 · AR
Steroid Receptor Coactivators (SRC-3) in Prostate Cancer
$338,625Baylor College Of Medicine · R01 · FY2002 · DK
CATHEPSIN K AS A LINK BETWEEN OBESITY, INFLAMMATION AND PROSTATE CANCER: POTENTIAL THERAPEUTIC IMPLICATIONS
$338,625Wayne State University · · FY2008 · Department of the Army
Steroid Receptor Coactivators (SRC-3) in Prostate Cancer
$338,625Baylor College Of Medicine · R01 · FY2005 · DK
Coactivators and Androgen Receptors in Prostate Cancer
$338,625Baylor College Of Medicine · R01 · FY2005 · DK
Steroid Receptor Coactivators (SRC-3) in Prostate Cancer
$338,625Baylor College Of Medicine · R01 · FY2004 · DK
Coactivators and Androgen Receptors in Prostate Cancer
$338,625Baylor College Of Medicine · R01 · FY2004 · DK
Steroid Receptor Coactivators (SRC-3) in Prostate Cancer
$338,625Baylor College Of Medicine · R01 · FY2003 · DK
Coactivators and Androgen Receptors in Prostate Cancer
$338,625Baylor College Of Medicine · R01 · FY2003 · DK
MDA-7/IL-24: Therapy of Ovarian Cancer
$338,625David T Curiel · Virginia Commonwealth University · P01 · FY2009 · CA
Studies of Protein Glycosylation
$338,622Carolyn R Bertozzi · University Of California Berkeley · R01 · FY2012 · GM
MYOSIN VI FUNCTION AND MECHANISM
$338,580Kathryn G Miller · Washington University · R01 · FY2010 · GM
Activation of androgen biosynthesis and drug metabolism by cytochrome b5
$338,571Richard J Auchus · University Of Michigan At Ann Arbor · R01 · FY2017 · GM
Telomeres, telomerase and chemotherapy: Bench to bedside
$338,540Jessie L.-S. Au · Optimum Therapeutics, Llc · R01 · FY2008 · CA
Prostate carcinogenesis and PKC signaling
$338,520Marcelo Gabriel Kazanietz · University Of Pennsylvania · R01 · FY2011 · CA
DOES RIPK2 PROMOTE PROSTATE CANCER PROGRESSION BY ACTIVATING THE MAX:MYC AND ONECUT2 PATHWAYS?
$338,520Cedars-Sinai Medical Center · · FY2018 · Department of the Army
Animal Core
$338,518Evan Todd Keller · University Of Michigan At Ann Arbor · P01 · FY2009 · CA
The Germ Cell Gene TDRD1 as a Novel Prostate Cancer Biomarker
$338,508Bin He · Methodist Hospital Research Institute · R01 · FY2020 · CA
Cancer cell selective killing nanoparticle for advanced ovarian cancer treatment
$338,506Peisheng Xu · University Of South Carolina At Columbia · R01 · FY2022 · CA
Cancer cell selective killing nanoparticle for advanced ovarian cancer treatment
$338,506Peisheng Xu · University Of South Carolina At Columbia · R01 · FY2025 · CA
8P22 ALTERATIONS, IN PROSTATE, BREAST AND ESOPHAGEAL CA
$338,483Ohio State University · R01 · FY2004 · CA
KLF6 Gene and Clinical Correlates in Prostate Cancer
$338,423New York University School Of Medicine · R01 · FY2005 · CA
CONTROL OF AKT ACTIVITY IN PROSTATE CANCER
$338,410University Of North Carolina At Chapel Hill · · FY2008 · Department of Defense
Combination Therapies for Cancer Treatment
$338,392David J Waxman · Boston University (Charles River Campus) · R01 · FY2010 · CA